Search – Page 212 – Indianapolis Business Journal

Home » Search

Articles

Mounjaro price hike fuels UK pharmacy battle to retain customers

August 29, 2025 | Bloomberg News

Eli Lilly and Co. announced this month it would raise the weight-loss treatment’s price by as much as 170%, presenting pharmacies with a dilemma about how much they would pass on to patients.

Kia Wright: Investing in our youth is state’s economic imperative

August 29, 2025 | Kia Wright

When young people connect with leaders who share their cultural background, they gain professional skills and confidence in their ability to succeed.

World Health Organization adds Mounjaro to its list of essential medicines

September 5, 2025 | Bloomberg News

The recommendation applies to a range of GLP-1 drugs that also includes Novo Nordisk’s Ozempic and Lilly’s older diabetes treatment, Trulicity.

State’s exit from GM site ownership signals new economic development approach

September 5, 2025 | Mickey Shuey

“The governor has been very clear: We’re just not in the land development business, and it’s not a core competency,” Commerce Secretary David Adams told IBJ.

Elanco reports pet parasite treatment quickly hit $100M blockbuster status

September 8, 2025 | Daniel Lee

The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis.

Lilly rival Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs

September 10, 2025 | Associated Press

The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational complexity and speed up decision-making as the company faces a more competitive market for obesity drugs.

Indianapolis-based ag giant Corteva considering split-up, report says

September 13, 2025 | IBJ Staff

The $50 billion company is considering dividing its seed and pesticide businesses into separate companies, the Wall Street Journal reported

Eli Lilly to build $5B plant in Virginia—first of 4 U.S. sites to be named this year

September 16, 2025 | Daniel Lee

Indianapolis-based Lilly said the new plant would create more than 650 jobs in Virginia for engineers, scientists, operations personnel and lab technicians, as well as 1,800 construction jobs.

FDA takes aim at Hims and other telehealth services in drug advertising crackdown

September 16, 2025 | Associated Press

The Food and Drug Administration on Tuesday posted more than 100 letters to various drug and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered on lower-cost versions of blockbuster obesity injections.

Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

September 17, 2025 | Bloomberg News

Eli Lilly and Co. and Novo Nordisk have been locked in a fierce battle to control the obesity market, which is projected to reach $100 billion by the end of the decade.

Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market

September 18, 2025 | The Washington Post

Ahead of decisions by the FDA, both Novo Nordisk and Eli Lilly are readying production for their weight-loss pills, having been unable to keep up with demand for their shots that exploded in popularity.

Lilly brain health campaign aims to ward off dementia

September 19, 2025 | Daniel Lee

Eli Lilly and Co. this month launched a public awareness campaign called Brain Health Matters, which features actress Julianne Moore urging people to be proactive as they age to lower their risk of dementia, including Alzheimer’s disease.

Cecil Bohanon and John Horowitz: Owsley showed how art of altruism benefits all

September 19, 2025 | Cecil Bohanon and John Horowitz

The beneficence of the Ball family has long blessed Muncie.

Potential breakup of Corteva plants kernel of uncertainty

September 19, 2025 | Daniel Lee

Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the company’s presence in Indianapolis as well as the state’s agriculture industry.

How Indy-area businesses use AI to train employees

September 19, 2025 | Sam Stall

The Carmel-based company, Murray Mentor, has created a voice-in-the-ear AI program that allows novice factory employees to tap the expertise of some of the most-seasoned employees—even if those employees retired long ago.

Weight-loss drugs can cut future health costs. The fight is over who pays now.

September 22, 2025 | The Washington Post

Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

September 22, 2025 | Associated Press

Demand for obesity treatments has soared recently, due to unprecedented weight loss provided by regular injections of market leaders Wegovy from Novo Nordisk and Zepbound from Indianapolis-based Eli Lilly and Co.

Eli Lilly plans to make highly anticipated weight-loss pill at new $6.5B Texas plant

September 23, 2025 | Daniel Lee

The $6.5 billion Houston-area plant is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 billion reshoring investment unveiled early this year.

IU group among finalists for up to $160M to develop musculoskeletal health hub

September 23, 2025 | IBJ Staff

The goal of the National Science Foundation’s Engines program is to grow regional innovation ecosystems.

Trump to put import taxes on pharmaceuticals, kitchen cabinets, furniture and heavy trucks

September 25, 2025 | Associated Press

Trump said on Truth Social that the pharmaceutical tariffs would not apply to companies that are building manufacturing plants in the United States, which he defined as either “breaking ground” or being “under construction.”

« Previous 1 … 210 211 212 213 214 … 221 Next »

Search Results

4,409 results for '\"eli lilly\"'